Transcatheter valve in valve replacement in stentless prosthetic aortic valves compared to a surgical approach: The lunch is good, but not free!

2022 ◽  
Vol 99 (1) ◽  
pp. 193-194
Author(s):  
Errol Inci ◽  
Peter C. Block
Keyword(s):  
Valve Replacement ◽  
Surgical Approach ◽  
Aortic Valves ◽  
Valve In Valve ◽  
Transcatheter Valve

scholarly journals Reoperative Surgical Aortic Valve Replacement Versus Transcatheter Valve-in-Valve Replacement for Degenerated Bioprosthetic Aortic Valves

2016 ◽  
Vol 102 (5) ◽  
pp. 1452-1458 ◽  
Author(s):  
Julius I. Ejiofor ◽  
Maroun Yammine ◽  
Morgan T. Harloff ◽  
Siobhan McGurk ◽  
Jochen D. Muehlschlegel ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Surgical Aortic Valve Replacement ◽  
Aortic Valves ◽  
Valve In Valve ◽  
Transcatheter Valve

Transcatheter valve-in-valve replacement of degenerated bioprosthetic aortic valves: A single Australian Centre experience

2014 ◽  
Vol 15 (8) ◽  
pp. 388-392 ◽  
Author(s):  
Vijayakumar Subban ◽  
Michael Savage ◽  
James Crowhurst ◽  
Karl Poon ◽  
Alexander Incani ◽  
...  
Keyword(s):  
Valve Replacement ◽  
Aortic Valves ◽  
Valve In Valve ◽  
Transcatheter Valve

scholarly journals Transcatheter valve-in-valve-in-valve replacement in tricuspid position in a patient with pre-existing permanent dual-chamber pacemaker

2021 ◽  
Author(s):  
Philipp Lake ◽  
Elmar W. Kuhn ◽  
Victor Mauri ◽  
Sascha Macherey ◽  
Julia Kaliba ◽  
...  
Keyword(s):  
Valve Replacement ◽  
Dual Chamber ◽  
Dual Chamber Pacemaker ◽  
Valve In Valve ◽  
Transcatheter Valve

Graphic abstract

Short-Term Outcome of Redo Aortic Valve and Transcatheter Valve-in-Valve Replacement for Failing Stentless Aortic Valve Prostheses: A Single-center Experience

2021 ◽  
Author(s):  
D. Fedorov ◽  
R. Bauernschmitt ◽  
L. K. Eschenbach ◽  
S. Bauer ◽  
J. P. Grunebaum ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Valve Replacement ◽  
Single Center ◽  
Short Term ◽  
Term Outcome ◽  
Single Center Experience ◽  
Short Term Outcome ◽  
Valve In Valve ◽  
Valve Prostheses ◽  
Transcatheter Valve

scholarly journals Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world outcomes

2020 ◽  
Vol 41 (29) ◽  
pp. 2747-2755 ◽  
Author(s):  
Sameer A Hirji ◽  
Edward D Percy ◽  
Cheryl K Zogg ◽  
Alexandra Malarczyk ◽  
Morgan T Harloff ◽  
...  
Keyword(s):  
High Risk ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Surgical Aortic Valve Replacement ◽  
Aortic Valves ◽  
Transcatheter Aortic Valve ◽  
Risk Patients ◽  
Valve In Valve

Abstract Aims We sought to perform a head-to-head comparison of contemporary 30-day outcomes and readmissions between valve-in-valve transcatheter aortic valve replacement (VIV-TAVR) patients and a matched cohort of high-risk reoperative surgical aortic valve replacement (re-SAVR) patients using a large, multicentre, national database. Methods and results We utilized the nationally weighted 2012–16 National Readmission Database claims to identify all US adult patients with degenerated bioprosthetic aortic valves who underwent either VIV-TAVR (n = 3443) or isolated re-SAVR (n = 3372). Thirty-day outcomes were compared using multivariate analysis and propensity score matching (1:1). Unadjusted, VIV-TAVR patients had significantly lower 30-day mortality (2.7% vs. 5.0%), 30-day morbidity (66.4% vs. 79%), and rates of major bleeding (35.8% vs. 50%). On multivariable analysis, re-SAVR was a significant risk factor for both 30-day mortality [adjusted odds ratio (aOR) of VIV-SAVR (vs. re-SAVR) 0.48, 95% confidence interval (CI) 0.28–0.81] and 30-day morbidity [aOR for VIV-TAVR (vs. re-SAVR) 0.54, 95% CI 0.43–0.68]. After matching (n = 2181 matched pairs), VIV-TAVR was associated with lower odds of 30-day mortality (OR 0.41, 95% CI 0.23–0.74), 30-day morbidity (OR 0.53, 95% CI 0.43–0.72), and major bleeding (OR 0.66, 95% CI 0.51–0.85). Valve-in-valve TAVR was also associated with shorter length of stay (median savings of 2 days, 95% CI 1.3–2.7) and higher odds of routine home discharges (OR 2.11, 95% CI 1.61–2.78) compared to re-SAVR. Conclusion In this large, nationwide study of matched high-risk patients with degenerated bioprosthetic aortic valves, VIV-TAVR appears to confer an advantage over re-SAVR in terms of 30-day mortality, morbidity, and bleeding complications. Further studies are warranted to benchmark in low- and intermediate-risk patients and to adequately assess longer-term efficacy.

A CASE OF VALVE-IN-VALVE TRANSCATHETER VALVE REPLACEMENT IN BACTERIAL ENDOCARDITIS

2019 ◽  
Vol 73 (9) ◽  
pp. 2993
Author(s):  
Rohini Manaktala ◽  
Stephen Ramee ◽  
Patrick Parrino ◽  
Jose Tafur Soto
Keyword(s):  
Valve Replacement ◽  
Bacterial Endocarditis ◽  
Valve In Valve ◽  
Transcatheter Valve Replacement ◽  
Transcatheter Valve

scholarly journals Transfemoral transcatheter valve-in-valve-in-valve replacement

2016 ◽  
Vol 152 (2) ◽  
pp. 622-623 ◽  
Author(s):  
Stephane Leung Wai Sang ◽  
Jay Giri ◽  
Prashanth Vallabhajosyula
Keyword(s):  
Valve Replacement ◽  
Valve In Valve ◽  
Transcatheter Valve

scholarly journals Transcatheter Valve-In-Valve Implantation for Failed Balloon-Expandable Transcatheter Aortic Valves

2012 ◽  
Vol 5 (5) ◽  
pp. 571-577 ◽  
Author(s):  
Stefan Toggweiler ◽  
David A. Wood ◽  
Josep Rodés-Cabau ◽  
Samir Kapadia ◽  
Alexander B. Willson ◽  
...  
Keyword(s):  
Aortic Valves ◽  
Valve In Valve ◽  
Transcatheter Valve ◽  
Valve Implantation

scholarly journals TRANSCATHETER VALVE-IN-VALVE REPLACEMENT VERSUS REDO AORTIC VALVE SURGERY FOR BIOPROSTHETIC AORTIC VALVE DYSFUNCTION: A META-ANALYSIS

2018 ◽  
Vol 71 (11) ◽  
pp. A1411
Author(s):  
Saroj Neupane ◽  
Hemindermeet Singh ◽  
Johannes Lämmer ◽  
Hussein Othman ◽  
Hiroshi Yamasaki ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Valve Replacement ◽  
Meta Analysis ◽  
Valve Surgery ◽  
Aortic Valve Surgery ◽  
Valve Dysfunction ◽  
Valve In Valve ◽  
Transcatheter Valve

scholarly journals Transcatheter Aortic Valve-in-Valve Replacement for Degenerated Stentless Bioprosthetic Aortic Valves

2019 ◽  
Vol 12 (13) ◽  
pp. 1217-1226 ◽  
Author(s):  
Matthew Miller ◽  
Mandy Snyder ◽  
Benjamin D. Horne ◽  
James R. Harkness ◽  
John R. Doty ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Valve Replacement ◽  
Aortic Valves ◽  
Transcatheter Aortic Valve ◽  
Valve In Valve
Sign in / Sign up

Export Citation Format

Share Document